Citations

Clear

334 citation(s) found for "Jacobs, C".

Crizanlizumab and sickle cell disease: When should medications have their approval status revoked?
Jacobs, Jeremy W. , Stephens, Laura D. , Chooljian, David M. , Sharma, Deva , Adkins, Brian D. , Booth, Garrett S. , Jacobs, Jeremy W , Booth, Garrett , Adkins, Brian David , Stephens, Laura

Mayo Clinic

American Journal of Hematology | February 27, 2024 | Volume: 99 | Issue: 6 | Pages: 1016-1018

10.1002/ajh.27275 | PMID 38409818 Get It

Clinical attachment loss is cross‐sectionally associated with elevated glucose among adults without diabetes
Adam, Hamdi S , Molinsky, Rebecca , Bohn, Bruno , Roy, Sumith , Rosenbaum, Michael , Paster, Bruce J. , Colombo, P.C. , Desvarieux, Moı̈se, Jacobs, David R. , Demmer, Ryan T. , Papapanou, Panos N , Molinsky, Rebecca L , Demmer, Ryan T , Jacobs, David R , Yuzefpolskaya, M.

Mayo Clinic

Journal of Clinical Periodontology | February 12, 2024 | Volume: 51 | Issue: 5 | Pages: 522-535

10.1111/jcpe.13945 | PMID 38343130 Get It

AbstractAimWe investigated whether periodontal measures are cross‐sectionally associated with prediabetes and cardiometabolic biomarkers among non‐diabetic younger adults.Materials and MethodsOne thousand seventy‐one participants (mean age = 32.2 years [SE = 0.3]; 73% female) from the Oral Infections, Glucose Intolerance and Insulin Resistance Study were enrolled. Full‐mouth clinical attachment loss (fm‐CAL), probing depth (fm‐PD) and bleeding on probing were ascertained. Interproximal CAL (i‐CAL) and probing depths (i‐PD) served as our primary exposures. Glucose, HbA1c, insulin and insulin resistance (HOMA‐IR) outcomes were assessed from fasting blood. Prediabetes was defined per American Diabetes Association guidelines. Prediabetes prevalence ratios (PR [95% CI]) and mean [SE] cardiometabolic biomarkers were regressed on periodontal variables via multivariable robust variance Poisson regression or multivariable linear regression.ResultsPrevalence of prediabetes was 12.5%. Fully adjusted prediabetes PR in Tertiles 3 versus 1 of mean i‐CAL was 2.42 (1.77, 3.08). Fully adjusted fasting glucose estimates across i‐CAL tertiles were 83.29 [0.43], 84.31 [0.37], 86.48 [0.46]; p for trend <.01. Greater percent of sites with i‐PD ≥3 mm showed elevated natural‐log‐HOMA‐IR after adjustment (0%–12% of sites = 0.33 [0.03], 13%–26% of sites = 0.39 [0.03], ≥27% of sites = 0.42 [0.03]; p for trend = .04).Conclusionsi‐CAL (vs. fm‐CAL) was associated with elevated fasting glucose and prediabetes, whereas i‐PD (vs. fm‐PD) was associated with insulin resistance. Future studies are needed to examine periodontal disease and incident prediabetes.
Gender Representation on Editorial Boards of JAMA Network Journals
Schaechter, Judith D. , Booth, Garrett S. , Dupont, William D. , Silver, Julie , Booth, Garrett , Jacobs, Jeremy W. , Silver, Julie K.

Mayo Clinic

Journal of Women's Health | February 8, 2024 | Volume: 33 | Issue: 4 | Pages: 446-452

10.1089/jwh.2023.0685 | PMID 38330429 Get It

Spike ripples localize the epileptogenic zone best: an international intracranial study
Shi, Wen , Shaw, Dana , Walsh, Katherine G. , Han, Xue , Eden, Uri T. , Gliske, S. , Jacobs, Julia , Brinkmann, Benjamin H. , Worrell, Gregory A. , Kramer, Mark , Chu, Catherine J. , Gliske, Stephen V , Brinkmann, Benjamin H , Worrell, Gregory A , Kramer, Mark A , Chu, Catherine J , Richardson, Robert Mark , Stacey, William C. , Frauscher, Birgit , Thomas, John Paul

Mayo Clinic

Brain | February 7, 2024 | Volume: 147 | Issue: 7 | Pages: 2496-2506

10.1093/brain/awae037 | PMID 38325327 Get It

Abstract We evaluated whether spike ripples, the combination of epileptiform spikes and ripples, provide a reliable and improved biomarker for the epileptogenic zone compared with other leading interictal biomarkers in a multicentre, international study. We first validated an automated spike ripple detector on intracranial EEG recordings. We then applied this detector to subjects from four centres who subsequently underwent surgical resection with known 1-year outcomes. We evaluated the spike ripple rate in subjects cured after resection [International League Against Epilepsy Class 1 outcome (ILAE 1)] and those with persistent seizures (ILAE 2–6) across sites and recording types. We also evaluated available interictal biomarkers: spike, spike-gamma, wideband high frequency oscillation (HFO, 80–500 Hz), ripple (80–250 Hz) and fast ripple (250–500 Hz) rates using previously validated automated detectors. The proportion of resected events was computed and compared across subject outcomes and biomarkers. Overall, 109 subjects were included. Most spike ripples were removed in subjects with ILAE 1 outcome (P &lt; 0.001), and this was qualitatively observed across all sites and for depth and subdural electrodes (P &lt; 0.001 and P &lt; 0.001, respectively). Among ILAE 1 subjects, the mean spike ripple rate was higher in the resected volume (0.66/min) than in the non-removed tissue (0.08/min, P &lt; 0.001). A higher proportion of spike ripples were removed in subjects with ILAE 1 outcomes compared with ILAE 2–6 outcomes (P = 0.06). Among ILAE 1 subjects, the proportion of spike ripples removed was higher than the proportion of spikes (P &lt; 0.001), spike-gamma (P &lt; 0.001), wideband HFOs (P &lt; 0.001), ripples (P = 0.009) and fast ripples (P = 0.009) removed. At the individual level, more subjects with ILAE 1 outcomes had the majority of spike ripples removed (79%, 38/48) than spikes (69%, P = 0.12), spike-gamma (69%, P = 0.12), wideband HFOs (63%, P = 0.03), ripples (45%, P = 0.01) or fast ripples (36%, P &lt; 0.001) removed. Thus, in this large, multicentre cohort, when surgical resection was successful, the majority of spike ripples were removed. Furthermore, automatically detected spike ripples localize the epileptogenic tissue better than spikes, spike-gamma, wideband HFOs, ripples and fast ripples.
Perceived Impact of Society for Research on Nicotine and Tobacco Health Equity Network’s Pre-conference Workshops on Attendees’ Professional Development
Jacobs, Wura , Jackson, Asti , Martinez, Sydney A. , Addicott, Merideth A. , Denlinger-Apte, Rachel , Mithi, Vita , Patten, Christi A. , Castro, Yessenia , Tan, Andy S L , Denlinger-Apte, Rachel L , Mithi, Vita , Patten, Christi , Kypriotakis, George

Mayo Clinic

Nicotine and Tobacco Research | February 1, 2024 | Volume: 26 | Issue: 7 | Pages: 959-960

10.1093/ntr/ntae018 | PMID 38297962 Get It

Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review
Jacobs, Jeremy W. , Sharma, Deva , Stephens, Laura D. , Rinder, Henry M. , Wheeler, Allison P. , Gerberi, Dana , Goel, Ruchika , Tormey, Christopher A. , Booth, Garrett S. , Bloch, Evan M. , Adkins, Brian D. , Rinder, Henry M , Wheeler, Allison P , Goel, Ruchika , Tormey, Christopher A , Booth, Garrett , Bloch, Evan M , Adkins, Brian David , Jacobs, Jeremy W , Stephens, Laura , Villalba, Cristina A. Figueroa , Woo, Jennifer S.

Mayo Clinic

British Journal of Haematology | January 31, 2024 | Volume: 204 | Issue: 4 | Pages: 1500-1506

10.1111/bjh.19313 | PMID 38291731 Get It

SummaryThe thrombotic risk with haemoglobin C trait (HbAC) or haemoglobin C disease (HbCC) is unclear. However, individuals with HbCC have demonstrated chronic haemolysis, higher blood viscosity and altered rheology when compared to individuals with wild‐type haemoglobin (HbAA). These physiological alterations may theoretically translate to increased risk of thrombosis; therefore, a systematic literature review was performed to investigate the possible association between HbAC and/or HbCC and thrombosis. Twenty‐two studies met inclusion criteria representing 782 individuals with HbAC (n = 694) or HbCC (n = 88). Fifteen studies described the presence/absence of venous thromboembolism (VTE) in patients with HbAC (n = 685) or HbCC (n = 79), while seven studies described patients with HbAC (n = 9) or HbCC (n = 9) and arterial thrombosis. Most (n = 20) studies were case reports or case series; however, two studies suggested a potential increased VTE risk with HbAC compared to HbAA in (i) all patients (OR 2.2, 95% CI: 0.9–5.5) and in (ii) pregnant individuals (RR 3.7, 95% CI 0.9–16). This review is the largest assessment of patients with HbC trait or disease and thrombosis to date; despite its limitations, the findings suggest HbC may be a predisposing risk factor to thrombosis. Prospective cohort studies are warranted to definitively elucidate the risk of thrombosis in this population.
Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro‐magnetic tissue properties study group
Bilgiç, Berkin , Costagli, Mauro , Chan, Kwok‐Shing , Duyn, Jeff H. , Lee, Jongho , Li, Xu , Liu, Chunlei , Marques, José P. , Schweser, Ferdinand , Straub, Sina , Group, ISMRM Electro‐Magnetic Tissue Properties Study, Bilgic, Berkin , Costagli, Mauro , Chan, Kwok-Shing , Langkammer, Christian , Lee, Jongho , Li, Xu , Liu, Chunlei , Marques, José P , Robinson, Simon Daniel , Schweser, Ferdinand , Shmueli, Karin , Spincemaille, Pascal , Straub, Sina , Milovic, Carlos , Spincemaille, Pascal , Zijl, Peter C.M. van , Wang, Yi , Group, ISMRM Electro‐Magnetic Tissue Properties Study

Mayo Clinic

Magnetic Resonance in Medicine | January 22, 2024 | Volume: 91 | Issue: 5 | Pages: 1834-1862

10.1002/mrm.30006 | PMID 38247051 Get It

AbstractThis article provides recommendations for implementing QSM for clinical brain research. It is a consensus of the International Society of Magnetic Resonance in Medicine, Electro‐Magnetic Tissue Properties Study Group. While QSM technical development continues to advance rapidly, the current QSM methods have been demonstrated to be repeatable and reproducible for generating quantitative tissue magnetic susceptibility maps in the brain. However, the many QSM approaches available have generated a need in the neuroimaging community for guidelines on implementation. This article outlines considerations and implementation recommendations for QSM data acquisition, processing, analysis, and publication. We recommend that data be acquired using a monopolar 3D multi‐echo gradient echo (GRE) sequence and that phase images be saved and exported in Digital Imaging and Communications in Medicine (DICOM) format and unwrapped using an exact unwrapping approach. Multi‐echo images should be combined before background field removal, and a brain mask created using a brain extraction tool with the incorporation of phase‐quality‐based masking. Background fields within the brain mask should be removed using a technique based on SHARP or PDF, and the optimization approach to dipole inversion should be employed with a sparsity‐based regularization. Susceptibility values should be measured relative to a specified reference, including the common reference region of the whole brain as a region of interest in the analysis. The minimum acquisition and processing details required when reporting QSM results are also provided. These recommendations should facilitate clinical QSM research and promote harmonized data acquisition, analysis, and reporting.
How the United States syphilis epidemic may portend a resurgence of an unusual hematologic condition: The connection between syphilis and paroxysmal cold hemoglobinuria
Jacobs, Jeremy W. , Booth, Garrett S. , Adkins, Brian D. , Adkins, Brian David , Jacobs, Jeremy W , Booth, Garrett , Woo, Jennifer S. , Stephens, Laura D.

Mayo Clinic

American Journal of Hematology | December 28, 2023 | Volume: 99 | Issue: 3 | Pages: 484-485

10.1002/ajh.27190 | PMID 38151909 Get It

Challenges in recognising paroxysmal cold hemoglobinuria
Jacobs, Jeremy W. , Booth, Garrett S. , Villalba, Cristina A. Figueroa , Adkins, Brian D. , Jacobs, Jeremy W , Booth, Garrett , Adkins, Brian David , Woo, Jennifer S. , Stephens, Laura D.

Mayo Clinic

Transfusion Medicine | December 28, 2023 | Volume: 34 | Issue: 1 | Pages: 71-73

10.1111/tme.13024 | PMID 38151804 Get It

Discrepancies among studies reporting the prevalence of positive direct antiglobulin tests in the COVID‐19 patient population
Jacobs, Jeremy W. , Adkins, Brian D. , Booth, Garrett S. , Jacobs, Jeremy W , Booth, Garrett , Adkins, Brian David , Stephens, Laura D. , Woo, Jennifer S.

Mayo Clinic

Transfusion Medicine | December 28, 2023 | Volume: 34 | Issue: 3 | Pages: 234-235

10.1111/tme.13023 | PMID 38151773 Get It